Меню
Идёт набор NCT07022925

A Trial to Investigate the Accuracy of a Wearable Device in Collecting Data Related to Perimenopausal Symptoms in Women

— Наблюдательное Perimenopause Perimenopausal Depression Perimenopausal Insomnia Perimenopausal Women

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
Это наблюдательное исследование: исследуемое лечение участникам по протоколу не назначают.
Кому может быть актуально
Состояния в реестре: Perimenopause, Perimenopausal Depression, Perimenopausal Insomnia, Perimenopausal Women. Базовые параметры: 35 лет — 55 лет · Женщины.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Канада
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

An Observational Virtual Trial to Investigate the Accuracy of a Wearable Device in Collecting Data Related to Perimenopausal Symptoms in Women

Обзор

The goal of this observational study is to investigate the accuracy of the device in characterizing perimenopausal and menopausal symptoms including vasomotor symptoms, anxiety, sleep quality compared to self-reported symptoms via an app. The main question it aims to answer is: What is the accuracy of the developed algorithm from the investigational device compared to daily self-report via an app in characterizing perimenopausal symptoms? Participants will be asked to wear IndentifyHer's wearable non-invasive sensor and complete a daily electronic diary and questionnaires on stress, anxiety, and sleep.

Первичные конечные точки

  • The accuracy of the developed algorithm from the investigational device compared to daily self-report questionnaire via an app in characterizing Vasomotor symptoms. [Срок оценки: Day 0 to 14]
  • The accuracy of the developed algorithm from the investigational device compared to daily self-report questionnaire via an app in characterizing anxiety [Срок оценки: Day 0 to 14]
  • The accuracy of the developed algorithm from the investigational device compared to daily self-report questionnaire via an app in characterizing sleep quality [Срок оценки: Day 0 to 14]
  • The accuracy of the developed algorithm from the investigational device compared to daily self-report questionnaire via an app in characterizing perimenopausal symptoms considering confounders [Срок оценки: Day 0 to 14]
  • The accuracy of the developed algorithm from the investigational device compared to daily self-report questionnaire via an app in characterizing perimenopausal symptoms considering confounders [Срок оценки: Day 0 to 14]

Критерии участия

Критерии включения

  • Females between 35-55 years of age, inclusive
  • Self-reported perimenopausal women experiencing hot flushes or night sweats
  • Individuals of child-bearing potential must confirm they are not pregnant, do not plan to become pregnant, and agree to use a medically approved method of birth control for the duration of the study. Acceptable methods of birth control include:
  • Double-barrier method
  • Intrauterine devices
  • Non-heterosexual lifestyle or agrees to use contraception if planning on changing to heterosexual partner(s)
  • Vasectomy of partner at least 6 months prior to screening
  • Abstinence
  • Agrees to maintain current lifestyle as much as possible throughout the study, including diet, exercise, supplements/medications, and sleep
  • Provided voluntary and informed consent to participate in the study
  • Generally healthy as determined by medical history with no unstable diagnosed medical conditions

Критерии исключения

  • Allergy or sensitivity to adhesive used for wearing the investigational device
  • Self-reported use of a pacemaker
  • Self-reported unstable diagnosed anxiety disorder
  • Self-reported sleep disorder requiring medical treatment
  • Self-reported skin conditions or sensitive skin around the area of application
  • Self-reported surgery in the past three months or individuals who have planned surgery during the course of the study
  • Alcohol intake average of ˃1 standard drink per day
  • Alcohol or drug abuse within the last 12 months that has required treatment
  • Current use of prescribed and/or over-the-counter (OTC) medications/supplements that may impact data recorded by the investigational device (see Section 7.3)
  • Participation in other clinical research studies 30 days prior to screening
  • Individuals who are unable to give informed consent
  • Any other condition or lifestyle factor, that may adversely affect the participant's ability to complete the study or its measures or pose significant risk to the participant

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Модель наблюдения
Другое

Центры проведения

Канада · 1 центр
  • KGK Science Inc. — London

Идентификаторы

NCT: NCT07022925 · 24IDCFI01

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗